| As of Date | 09/15/2026 |
| Registration | SEC, ERA - Active, 09/15/2026 |
| ADV Location | PARIS, France |
| Contact Info | +33 xxxxxxx |
| Websites |
|
Exempt Reporting Adviser
2B(2)- PF<150mn
|
|
| Private Fund GAV* | 4,327,201,914 |
| SMA’s | No |
| Private Funds | 11 |
| Count | GAV | |
|---|---|---|
| {{ TypeColumnLabel }} {{ item.FundType }} | Count{{ formatCount(item.FundsCount) }} | GAV{{ formatGAV(item.AUM) }} |
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck TickerG52441105 | Stock NameKESTRA MED TECHNOLOGIES LTD | $ Position$69,417,594 | % Position34.00% | $ Change | # Change |
| Stck Ticker603170101 | Stock NameMINERALYS THERAPEUTICS INC | $ Position$42,949,921 | % Position21.00% | $ Change | # Change |
| Stck Ticker05348Y105 | Stock NameAVALYN PHARMACEUTICALS INC | $ Position$30,609,806 | % Position15.00% | $ Change | # Change |
| Stck Ticker00860C102 | Stock NameAGOMAB THERAPEUTICS NV | $ Position$19,972,352 | % Position10.00% | $ Change | # Change |
| Stck Ticker30054Y107 | Stock NameEVOMMUNE INC | $ Position$18,499,547 | % Position9.00% | $ Change | # Change |
| Stck Ticker46124U107 | Stock NameINVENTIVA SA | $ Position$13,733,424 | % Position7.00% | $ Change | # Change |
| Stck Ticker00370M103 | Stock NameABIVAX SA | $ Position$10,410,938 | % Position5.00% | $ Change | # Change |
| Stck TickerB6S7WD106 | Stock NameNYXOAH S A | $ Position$882,276 | % Position0.00% | $ Change | # Change |